Nilandron is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Concordia Pharmaceuticals Inc.. The primary component is Nilutamide.
Product ID | 59212-111_1c7bf50a-82ee-49ac-b1bc-35d1a2e60f36 |
NDC | 59212-111 |
Product Type | Human Prescription Drug |
Proprietary Name | Nilandron |
Generic Name | Nilutamide |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2013-07-15 |
Marketing Category | NDA / NDA |
Application Number | NDA020169 |
Labeler Name | Concordia Pharmaceuticals Inc. |
Substance Name | NILUTAMIDE |
Active Ingredient Strength | 150 mg/1 |
Pharm Classes | Androgen Receptor Antagonists [MoA],Androgen Receptor Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2013-07-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020169 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2016-01-01 |
Marketing End Date | 2018-10-25 |
Marketing Category | NDA |
Application Number | NDA020169 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-07-15 |
Ingredient | Strength |
---|---|
NILUTAMIDE | 150 mg/1 |
SPL SET ID: | 5ccf0e9a-8935-4c8c-b883-b4967281eb4a |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
59212-111 | Nilandron | Nilutamide |
82454-0111 | Nilandron | Nilutamide |
62559-173 | Nilutamide | Nilutamide |
66993-212 | Nilutamide | Nilutamide |
82454-0212 | Nilutamide | Nilutamide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NILANDRON 74646174 1949186 Live/Registered |
CONCORDIA PHARMACEUTICALS INC. 1995-03-13 |